Ching-hua's practice covers a broad range of capital markets, corporate and finance matters. She has an extensive track record advising clients on their offerings of securities, including convertible or exchangeable bonds (including Hon Hai Foxconn, Formosa Plastics, Asia Cement, Ennoconn), American or Global depositary receipts (such as TSMC, AUO, Cathay Financial Holdings, Chailease Holding, TPK, Inotera, Parade, Oneness Biotech, etc.), Taiwan depositary receipts (Want Want China Holding, Super Coffee Group), supra notes or Formosa bonds (CABEI, CIBC, Natixis). Ching-hua is an experienced advisor on IPO transactions, having participated in Haidilao's Hong Kong IPO, ChipMOS Bermuda's US IPO, and Cayman company Crown Bioscience's Taiwan IPO. Recent milestone transactions that she has represented clients include reverse triangular merger between Pegatron and Casetek, privatization of TCC International Holdings, and ChipMOS' merger with offshore company with ADRs as merger consideration.
LL.M., University of Illinois at Urbana-Champaign (1999)
LL.B., National Taiwan University (1992)